1-1-12 Wash-in for Desflurane Low Flow Anesthesia
- Conditions
- Anesthesia
- Interventions
- Procedure: 1-1-12 wash-in
- Registration Number
- NCT02013882
- Lead Sponsor
- Khon Kaen University
- Brief Summary
We propose a new wash-in technique for desflurane low flow anesthesia with fresh gas flow of O2:N2O 1:1 L/min with desfluraene 12%.
The objective of this study is to identify time to achieve alveolar concentration of desflurane at1, 2, 3, 4, 5 and 6%.
- Detailed Description
The benefits of low flow anesthesia are economic, less pollution, more heat and humidity preservation but it requires appropriate wash-in phase. The current wash-in protocols are complicated and time consuming. We propose a new 1-1-12 desflurane wash-in protocol which is more simple and predictable.
The objective of this study is to identify time to achieve alveolar concentration of desflurane at 1, 2, 3, 4, 5 and 6% with 1-1-12 wash-in protocol.
All patients will receive iv propofol 2 mg/kg as induction agent and succinyl choline 1.5 mg/kg for intubation. Then the ventilation will be controlled to achieve end-tidal CO2 30-35 mmHg with O2:N2O 1:1 L/min with desflurane 12%. Time to achieve alveolar concentration of desflurane at 1, 2, 3, 4, 5 and 6% will be recorded and analyzed. After that, the concentration of desflurane and anesthetic technique will be adjusted to requirement of anesthesiologist.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 106
- ASA classification I-II
- age 18-64 years
- BMI > 35
- contraindicated for N2O
- with pulmonary or cardiac disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1-1-12 wash-in 1-1-12 wash-in wash-in using O2:N2O 1:1 L/min with desflurane 12%
- Primary Outcome Measures
Name Time Method Time (in second) to achieve alveolar concentration of desflurane 1, 2, 3, 4, 5 and 6% participants will be followed until alveolar concentration of desflurane reaches 6%, as expected of 15 minutes
- Secondary Outcome Measures
Name Time Method Heart rate participants will be followed until alveolar concentration of desflurane reaches 6%, as expected of 15 minutes
Trial Locations
- Locations (1)
Srinagarind Hospital
🇹ðŸ‡Khon Kaen, Thailand